» Articles » PMID: 18422456

Leishmania Infantum Promastigotes Reduce Entry of HIV-1 into Macrophages Through a Lipophosphoglycan-mediated Disruption of Lipid Rafts

Overview
Journal J Infect Dis
Date 2008 Apr 22
PMID 18422456
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Visceral leishmaniasis is now recognized as an opportunistic disease in patients infected with human immunodeficiency virus type 1 (HIV-1). We report here that Leishmania infantum promastigotes enhance HIV-1 replication in monocyte-derived macrophages (MDMs) at late time points in the virus growth curve but also that, surprisingly, a reduction in HIV-1 production is seen during the initial days after infection. This early effect is caused by a Leishmania-mediated inhibition of virus entry into MDMs through the action of lipophosphoglycan (LPG), the major promastigote surface glycolipid. The impact of LPG in the observed phenomenon was confirmed using LPG-defective lpg1-/- knockout mutant promastigotes. Our results suggest that the LPG-mediated effect results from the disruption of lipid rafts. Altogether, these findings suggest that the presence of Leishmania within the same cellular microenvironment leads to 2 opposite, time-dependent effects on HIV-1 replication. Leishmania and HIV-1 can thus establish complex interactions in their common natural host cells.

Citing Articles

A case report and literature review: diagnosis and treatment of human immunodeficiency virus coinfected with visceral leishmania by metagenomic next-generation sequencing in China.

Tang C, He S, Wang N, Chen L Ann Transl Med. 2022; 10(8):497.

PMID: 35571385 PMC: 9096369. DOI: 10.21037/atm-22-1351.


Sink or swim: lipid rafts in parasite pathogenesis.

Goldston A, Powell R, Temesvari L Trends Parasitol. 2012; 28(10):417-26.

PMID: 22906512 PMC: 9721446. DOI: 10.1016/j.pt.2012.07.002.


Leishmaniasis: complexity at the host-pathogen interface.

Kaye P, Scott P Nat Rev Microbiol. 2011; 9(8):604-15.

PMID: 21747391 DOI: 10.1038/nrmicro2608.


HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis.

Santos L, Marinho F, Altoe E, Vitorio B, Alves C, Britto C PLoS One. 2009; 4(3):e4918.

PMID: 19325703 PMC: 2656615. DOI: 10.1371/journal.pone.0004918.